Clinical Indications
- Staging of prostate cancer at initial diagnosis
- Detecting recurrence if PSA levels rise after treatment
- Monitoring response to chemotherapy or radiotherapy
- Identifying metastases in bones or lymph nodes
The Ga-68 PSMA PET/CT scan is a cutting-edge diagnostic tool providing unparalleled accuracy in staging prostate cancer, enabling doctors to develop precise, personalized treatment plans for optimal patient outcomes.
Scientific name: Ga-68 PSMA PET/CT Scan for Prostate Cancer
An advanced imaging procedure combining PET and CT scans using Ga-68 PSMA ligands. It specifically targets prostate cancer cells throughout the body, providing high-resolution mapping for staging and recurrence detection.